Aandeel 300832 SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen Shenzhen New Industries Biomedical Engineering Co., Ltd.

Aandelen

300832

CNE100003T39

slotkoers Shenzhen S.E.
Andere beurzen
 00:00:00 19-04-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
64,68 CNY +0,40% Intraday-grafiek van Shenzhen New Industries Biomedical Engineering Co., Ltd. -2,63% -17,29%
12/04 Shenzhen New Industries Biomedical Engineering's 2023 winst springt 25% omhoog MT
11/04 Shenzhen New Industries Biomedical Engineering Co, Ltd. rapporteert winstresultaten voor het volledige jaar eindigend op 31 december 2023 CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
Shenzhen New Industries Biomedical Engineering Gets Nod to Register Five Devices
Shenzhen New Industries Biomedical Engineering's 2023 Profit Jumps 25%
Shenzhen New Industries Biomedical Engineering Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Shenzhen New Industries Biomedical Engineering Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Shenzhen New Industries' Profit Jumps 32% in H1
Shenzhen New Industries Biomedical Engineering Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Shenzhen New Industries Biomedical Engineering Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 08 June 2023
Shenzhen New Industries Biomedical Engineering's Shareholders Plan To Unload Company Stakes
Certain A Shares of Shenzhen New Industries Biomedical Engineering Co., Ltd. are subject to a Lock-Up Agreement Ending on 12-MAY-2023.
Shenzhen New Industries Biomedical Engineering Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Shenzhen New Industries Biomedical Engineering Co., Ltd. Announces Profit Distribution Proposal for 2022
Shenzhen New Industries Biomedical Engineering Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Shenzhen Yinghe Brain Science Co., Ltd announced that it has received $14.800000 million in funding from Eli Lilly Investment Consulting Shanghai Co., Ltd., Shenzhen New Industries Biomedical Engineering Co., Ltd., Beijing Enlight Media Co., Ltd., Xi'an Xijiao 1896 Capital Management Co., Ltd., Shenzhen Qianhai BangQin Investment Co., Ltd. and other investors.
ANALYSEN DES TAGES von Dow Jones Newswires (18.01.2023)
Shenzhen New Industries Receives Provincial Registration Certificate for Parathyroid Hormone Kit
Shenzhen New Industries Biomedical Engineering Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Shenzhen New Industries Biomedical Engineering Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
Shenzhen New Industries Biomedical Engineering Co., Ltd. Implements Final Cash Dividend for 2021, Payable on 23 June 2022
Shenzhen New Industries Biomedical Engineering Co., Ltd. Approves Cash Dividend for 2021
Shenzhen New Industries Biomedical Engineering Co., Ltd. Announces Profit Distribution Plan for 2021
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers 300832
  4. Nieuws Shenzhen New Industries Biomedical Engineering Co., Ltd.
  5. Andere talen